Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rich, S. S.
Right arrow Articles by Concannon, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rich, S. S.
Right arrow Articles by Concannon, P.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 51:S288-S294, 2002
© 2002 by the American Diabetes Association, Inc.

Section 1: In Search of Diabetes Genes

Challenges and Strategies for Investigating the Genetic Complexity of Common Human Diseases

Stephen S. Rich1, and Patrick Concannon2

1 Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina
2 Virginia Mason Research Center, Seattle, Washington

There is substantial interest in the identification of genes underlying susceptibility to complex human diseases because of the potential utility of such genes in disease prediction or therapy. Type 1 diabetes is an example of one such disorder and is presumed to arise from the effect of multiple genes and environmental factors. One identified locus has a major effect on type 1 diabetes susceptibility (IDDM1), whereas other loci have significant, yet small, individual effects (IDDM2, IDDM15). It is unclear whether susceptibility for type 1 diabetes arises because of the effects of loci acting independently or whether there are important interactions between loci. Although genetic tools are continuing to be developed to enable examination of candidate regions, the means to identify and narrow "true" susceptibility regions continues to be limited by the lack of statistical power resulting from inadequately sized collections of families. This report provides an evaluation of the approaches for identification of regions harboring type 1 diabetes genes, methods to identify the gene regions that interact to define the risk for type 1 diabetes, and efforts to fine-map the variants responsible.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Nucleic Acids ResHome page
F. A. Kondrashov, A. Y. Ogurtsov, and A. S. Kondrashov
Bioinformatical assay of human gene morbidity
Nucleic Acids Res., March 12, 2004; 32(5): 1731 - 1737.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
A. S. Karban, T. Okazaki, C. I.M. Panhuysen, T. Gallegos, J. J. Potter, J. E. Bailey-Wilson, M. S. Silverberg, R. H. Duerr, J. H. Cho, P. K. Gregersen, et al.
Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis
Hum. Mol. Genet., January 1, 2004; 13(1): 35 - 45.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
K. R. Merikangas and N. Risch
Genomic Priorities and Public Health
Science, October 24, 2003; 302(5645): 599 - 601.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.